GSA CAPITAL PARTNERS LLP CUE CUE BIOPHARMA INC

Ownership history in GSA CAPITAL PARTNERS LLP  ·  19 quarters on record

AI Ownership Summary

GSA CAPITAL PARTNERS LLP reported CUE BIOPHARMA INC (CUE) in 19 quarterly 13F filings from 2023 Q4 through 2026 Q1. Peak portfolio weight reached 0.03% in 2024 Q1. The latest visible filing shows CUE at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this CUE ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was GSA CAPITAL PARTNERS LLP's position in CUE BIOPHARMA INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CUE was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.03% in 2024 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How GSA CAPITAL PARTNERS LLP held CUE — position size vs. price
% of Fund (quarterly)    CUE price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED 20,341 -96,921 -82.7% 0.00% $5 2026-05-08 $35.00
2025 Q1 REDUCED 21.7% -25.1% 117,262 -32,536 -21.7% 0.01% $107K 2025-05-08 $23.04
2024 Q4 REDUCED 48.6% -16.4% 149,798 -141,865 -48.6% 0.01% $163K 2025-02-07 $38.40
2024 Q3 ADDED 291,663 +14,104 +5.1% 0.02% $221K 2024-11-05 $51.30
2024 Q2 ADDED 277,559 +68,459 +32.7% 0.02% $344K 2024-08-15 $17.82
2024 Q1 ADDED 209,100 +195,148 +1398.7% 0.03% $395K 2024-05-03 $63.90
2023 Q4 REDUCED 23.6% -28.0% 13,952 -4,317 -23.6% 0.00% $37K 2024-02-16 $65.70
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About GSA CAPITAL PARTNERS LLP and CUE

These are the practical questions this page is built to answer before you even open the full history table.

How long has GSA CAPITAL PARTNERS LLP reported owning CUE?

GSA CAPITAL PARTNERS LLP reported CUE across 7 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported CUE position in GSA CAPITAL PARTNERS LLP's portfolio?

The largest reported portfolio weight for CUE was 0.03% in 2024 Q1.

What is the latest reported CUE position on this page?

The most recent filing on this page is 2026 Q1, when GSA CAPITAL PARTNERS LLP reported 20,341 shares, equal to 0.00% of portfolio, with an estimated market value of $5.

What does the chart on this CUE ownership page compare?

The chart compares GSA CAPITAL PARTNERS LLP's quarterly CUE portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did GSA CAPITAL PARTNERS LLP time their CUE position?

Based on 13F filing dates vs. subsequent CUE price moves, GSA CAPITAL PARTNERS LLP correctly timed 12 out of 18 reported position changes (67%). The annualised alpha on CUE relative to SPY over the holding period was -51.1%.

← Back to GSA CAPITAL PARTNERS LLP Holdings